Sosei R&D Ltd.
Records under this name other than patents Sosei R&D Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,915,303 | Glycopyrronium salts and their therapeutic use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,846,954 | Crystallisation and purification of glycopyrronium bromide Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,695,321 | Use of glycopyrrolate for treating tachycardia Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D606,854 | Child resistant container Term ended Term ended Dec 29, 2023 · From the USPTO record | Term ended | Term ended Dec 29, 2023 | From the USPTO record |
| US 8,029,768 | Treatment of respiratory diseases Formerly held Term ended Term ended Jul 26, 2023 · From the USPTO record | Term ended | Term ended Jul 26, 2023 | From the USPTO record |
| US D588,468 | Pharmaceutical dispensing device Term ended Term ended Mar 17, 2023 · From the USPTO record | Term ended | Term ended Mar 17, 2023 | From the USPTO record |
| US 7,368,104 | Treatment of respiratory diseases Formerly held Term ended Term ended Oct 19, 2021 · From the USPTO record | Term ended | Term ended Oct 19, 2021 | From the USPTO record |
| US 6,488,960 | Corticosteroid formulation Term ended Term ended Sep 13, 2021 · From the USPTO record | Term ended | Term ended Sep 13, 2021 | From the USPTO record |
| US 6,677,326 | Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration Formerly held Term ended Ended no later than Sep 13, 2021 · From the USPTO record | Term ended | Ended no later than Sep 13, 2021 | From the USPTO record |
| US 7,229,607 | Treatment of respiratory disease Formerly held Term ended Ended no later than Apr 9, 2021 · From the USPTO record | Term ended | Ended no later than Apr 9, 2021 | From the USPTO record |